Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Sectors

SoftBank finds Better option for $500m investment

The transaction hiked the onine mortgage platform developer's valuation 50% to $6bn in five months as it begins to prepare for an initial public offering.


Apr 12, 2021

Anjuke advances to IPO stage

The property service platform is set to list in Hong Kong, handing exits to 58.com, Agile, Chinachem, CSC Land, Country Garden, Henderson, NWD, SHKP, Tencent and Times Property.

Apr 12, 2021

Battery Resourcers charges up with $20m

Orbia Ventures led a round for the battery production technology provider that included TDK Ventures, Trumpf Venture, Doral Energy-Tech Ventures and InMotion Ventures.

Apr 12, 2021

Vaccitech shoots for US IPO

Alphabet, Tencent and Gilead Sciences are in line to achieve exits, after the vaccine developer filed to go public on the Nasdaq Global Market.

Apr 12, 2021

Artiva activates $100m IPO plans

The NK cancer drug provider has filed to go public in an offering which would enable GC and its GC Labcell subsidiary to exit.

Apr 12, 2021

Hologic hoists in Mobidiag

Autobio Diagnostics is set to exit the molecular diagnostic test provider through a purchase by women’s health-focused technology provider Hologic.

Apr 12, 2021

Salesforce joins Community with $40m investment

Salesforce has supplied additional funding for the text messaging platform operator, which is also backed by Sony, Live Nation and Twilio.

Apr 12, 2021

Snorkel AI pipes in $35m

GV returned for a series B round that increased the machine learning technology developer's overall funding to $50m.

Apr 12, 2021

Schroders shifts Carrick stake at discount

Schroder UK Public Private Trust, the rebranded fund previously led by Neil Woodford, has sold its shareholding in Carrick Therapeutics at a discount.

Apr 12, 2021

IceKredit gets series C2 funding

The Youzu Interactive-backed credit rating services provider has collected $34.8m in a series C2 round led by CDB-CDC Capital.

Apr 12, 2021

Oxford Endovascular enters series A stage

University of Oxford, OSI and Parkwalk Advisors all returned for Oxford Endovascular’s $10m series A round.

Apr 12, 2021

Vaccitech shoots for US IPO

Oxford spinout Vaccitech, which developed the technology underlying the university’s covid vaccine, has filed for an offering on the Nasdaq Global Market.

Apr 12, 2021
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here